1 Study Coverage 1.1 Chronic Idiopathic Constipation (CIC) Drugs Product Introduction 1.2 Market Segments 1.3 Key Chronic Idiopathic Constipation (CIC) Drugs Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate by Type 1.4.2 Lubiprostone 1.4.3 Linaclotide 1.4.4 Others 1.5 Market by Application 1.5.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate by Application 1.5.2 Hospitals & Clinics 1.5.3 Ambulatory Surgical Centres 1.5.4 Long Term Care Centres 1.5.5 Others 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size, Estimates and Forecasts 2.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue 2015-2026 2.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales 2015-2026 2.2 Global Chronic Idiopathic Constipation (CIC) Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026 2.3 Chronic Idiopathic Constipation (CIC) Drugs Historical Market Size by Region (2015-2020) 2.3.1 Global Chronic Idiopathic Constipation (CIC) Drugs Retrospective Market Scenario in Sales by Region: 2015-2020 2.3.2 Global Chronic Idiopathic Constipation (CIC) Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020 2.4 Chronic Idiopathic Constipation (CIC) Drugs Market Estimates and Projections by Region (2021-2026) 2.4.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Region (2021-2026) 2.4.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast by Region (2021-2026) 3 Global Chronic Idiopathic Constipation (CIC) Drugs Competitor Landscape by Players 3.1 Global Top Chronic Idiopathic Constipation (CIC) Drugs Sales by Manufacturers 3.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Manufacturers (2015-2020) 3.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Manufacturers (2015-2020) 3.2 Global Chronic Idiopathic Constipation (CIC) Drugs Manufacturers by Revenue 3.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Manufacturers (2015-2020) 3.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Chronic Idiopathic Constipation (CIC) Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Chronic Idiopathic Constipation (CIC) Drugs Revenue in 2019 3.2.5 Global Chronic Idiopathic Constipation (CIC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Chronic Idiopathic Constipation (CIC) Drugs Price by Manufacturers 3.4 Global Chronic Idiopathic Constipation (CIC) Drugs Manufacturing Base Distribution, Product Types 3.4.1 Chronic Idiopathic Constipation (CIC) Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Chronic Idiopathic Constipation (CIC) Drugs Product Type 3.4.3 Date of International Manufacturers Enter into Chronic Idiopathic Constipation (CIC) Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size by Type (2015-2020) 4.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2015-2020) 4.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2015-2020) 4.1.3 Chronic Idiopathic Constipation (CIC) Drugs Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Type (2021-2026) 4.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Type (2021-2026) 4.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast by Type (2021-2026) 4.2.3 Chronic Idiopathic Constipation (CIC) Drugs Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Chronic Idiopathic Constipation (CIC) Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Market Size by Application (2015-2026) 5.1 Global Chronic Idiopathic Constipation (CIC) Drugs Market Size by Application (2015-2020) 5.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2015-2020) 5.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2015-2020) 5.1.3 Chronic Idiopathic Constipation (CIC) Drugs Price by Application (2015-2020) 5.2 Chronic Idiopathic Constipation (CIC) Drugs Market Size Forecast by Application (2021-2026) 5.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Application (2021-2026) 5.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast by Application (2021-2026) 5.2.3 Global Chronic Idiopathic Constipation (CIC) Drugs Price Forecast by Application (2021-2026) 6 China by Players, Type and Application 6.1 China Chronic Idiopathic Constipation (CIC) Drugs Market Size YoY Growth 2015-2026 6.1.1 China Chronic Idiopathic Constipation (CIC) Drugs Sales YoY Growth 2015-2026 6.1.2 China Chronic Idiopathic Constipation (CIC) Drugs Revenue YoY Growth 2015-2026 6.1.3 China Chronic Idiopathic Constipation (CIC) Drugs Market Share in Global Market 2015-2026 6.2 China Chronic Idiopathic Constipation (CIC) Drugs Market Size by Players (International and Local Players) 6.2.1 China Top Chronic Idiopathic Constipation (CIC) Drugs Players by Sales (2015-2020) 6.2.2 China Top Chronic Idiopathic Constipation (CIC) Drugs Players by Revenue (2015-2020) 6.3 China Chronic Idiopathic Constipation (CIC) Drugs Historic Market Review by Type (2015-2020) 6.3.1 China Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type (2015-2020) 6.3.2 China Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Type (2015-2020) 6.3.3 China Chronic Idiopathic Constipation (CIC) Drugs Price by Type (2015-2020) 6.4 China Chronic Idiopathic Constipation (CIC) Drugs Market Estimates and Forecasts by Type (2021-2026) 6.4.1 China Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Type (2021-2026) 6.4.2 China Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast by Type (2021-2026) 6.4.3 China Chronic Idiopathic Constipation (CIC) Drugs Price Forecast by Type (2021-2026) 6.5 China Chronic Idiopathic Constipation (CIC) Drugs Historic Market Review by Application (2015-2020) 6.5.1 China Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application (2015-2020) 6.5.2 China Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Application (2015-2020) 6.5.3 China Chronic Idiopathic Constipation (CIC) Drugs Price by Application (2015-2020) 6.6 China Chronic Idiopathic Constipation (CIC) Drugs Market Estimates and Forecasts by Application (2021-2026) 6.6.1 China Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Application (2021-2026) 6.6.2 China Chronic Idiopathic Constipation (CIC) Drugs Revenue Forecast by Application (2021-2026) 6.6.3 China Chronic Idiopathic Constipation (CIC) Drugs Price Forecast by Application (2021-2026) 7 North America 7.1 North America Chronic Idiopathic Constipation (CIC) Drugs Market Size YoY Growth 2015-2026 7.2 North America Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Country 7.2.1 North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2015-2020) 7.2.2 North America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2015-2020) 7.2.3 U.S. 7.2.4 Canada 8 Europe 8.1 Europe Chronic Idiopathic Constipation (CIC) Drugs Market Size YoY Growth 2015-2026 8.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Country 8.2.1 Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Country 8.2.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country 8.2.3 Germany 8.2.4 France 8.2.5 U.K. 8.2.6 Italy 8.2.7 Russia 9 Asia Pacific 9.1 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Size YoY Growth 2015-2026 9.2 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Country 9.2.1 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Region (2015-2020) 9.2.2 Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region 9.2.3 China 9.2.4 Japan 9.2.5 South Korea 9.2.6 India 9.2.7 Australia 9.2.8 Taiwan 9.2.9 Indonesia 9.2.10 Thailand 9.2.11 Malaysia 9.2.12 Philippines 9.2.13 Vietnam 10 Latin America 10.1 Latin America Chronic Idiopathic Constipation (CIC) Drugs Market Size YoY Growth 2015-2026 10.2 Latin America Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Country 10.2.1 Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country 10.2.2 Latin America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Size YoY Growth 2015-2026 11.2 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Market Facts & Figures by Country 11.2.1 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Country 11.2.2 Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 Actavis 12.1.1 Actavis Corporation Information 12.1.2 Actavis Description and Business Overview 12.1.3 Actavis Sales, Revenue and Gross Margin (2015-2020) 12.1.4 Actavis Chronic Idiopathic Constipation (CIC) Drugs Products Offered 12.1.5 Actavis Recent Development 12.2 Chugai Pharmaceutical 12.2.1 Chugai Pharmaceutical Corporation Information 12.2.2 Chugai Pharmaceutical Description and Business Overview 12.2.3 Chugai Pharmaceutical Sales, Revenue and Gross Margin (2015-2020) 12.2.4 Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Products Offered 12.2.5 Chugai Pharmaceutical Recent Development 12.3 Ferring International Center 12.3.1 Ferring International Center Corporation Information 12.3.2 Ferring International Center Description and Business Overview 12.3.3 Ferring International Center Sales, Revenue and Gross Margin (2015-2020) 12.3.4 Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Products Offered 12.3.5 Ferring International Center Recent Development 12.4 Synergy Pharmaceuticals 12.4.1 Synergy Pharmaceuticals Corporation Information 12.4.2 Synergy Pharmaceuticals Description and Business Overview 12.4.3 Synergy Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 12.4.4 Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Products Offered 12.4.5 Synergy Pharmaceuticals Recent Development 12.5 Pfizer 12.5.1 Pfizer Corporation Information 12.5.2 Pfizer Description and Business Overview 12.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020) 12.5.4 Pfizer Chronic Idiopathic Constipation (CIC) Drugs Products Offered 12.5.5 Pfizer Recent Development 12.6 GlaxoSmithKline 12.6.1 GlaxoSmithKline Corporation Information 12.6.2 GlaxoSmithKline Description and Business Overview 12.6.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020) 12.6.4 GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Products Offered 12.6.5 GlaxoSmithKline Recent Development 12.7 Roche Holding 12.7.1 Roche Holding Corporation Information 12.7.2 Roche Holding Description and Business Overview 12.7.3 Roche Holding Sales, Revenue and Gross Margin (2015-2020) 12.7.4 Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Products Offered 12.7.5 Roche Holding Recent Development 12.8 Sanofi 12.8.1 Sanofi Corporation Information 12.8.2 Sanofi Description and Business Overview 12.8.3 Sanofi Sales, Revenue and Gross Margin (2015-2020) 12.8.4 Sanofi Chronic Idiopathic Constipation (CIC) Drugs Products Offered 12.8.5 Sanofi Recent Development 12.9 Bayer 12.9.1 Bayer Corporation Information 12.9.2 Bayer Description and Business Overview 12.9.3 Bayer Sales, Revenue and Gross Margin (2015-2020) 12.9.4 Bayer Chronic Idiopathic Constipation (CIC) Drugs Products Offered 12.9.5 Bayer Recent Development 12.10 Salix Pharmaceuticals 12.10.1 Salix Pharmaceuticals Corporation Information 12.10.2 Salix Pharmaceuticals Description and Business Overview 12.10.3 Salix Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 12.10.4 Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Products Offered 12.10.5 Salix Pharmaceuticals Recent Development 12.11 Actavis 12.11.1 Actavis Corporation Information 12.11.2 Actavis Description and Business Overview 12.11.3 Actavis Sales, Revenue and Gross Margin (2015-2020) 12.11.4 Actavis Chronic Idiopathic Constipation (CIC) Drugs Products Offered 12.11.5 Actavis Recent Development 12.12 Ironwood Pharmaceuticals 12.12.1 Ironwood Pharmaceuticals Corporation Information 12.12.2 Ironwood Pharmaceuticals Description and Business Overview 12.12.3 Ironwood Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 12.12.4 Ironwood Pharmaceuticals Products Offered 12.12.5 Ironwood Pharmaceuticals Recent Development 12.13 Progenics Pharmaceuticals 12.13.1 Progenics Pharmaceuticals Corporation Information 12.13.2 Progenics Pharmaceuticals Description and Business Overview 12.13.3 Progenics Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 12.13.4 Progenics Pharmaceuticals Products Offered 12.13.5 Progenics Pharmaceuticals Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter’s Five Forces Analysis 13.5 Primary Interviews with Key Chronic Idiopathic Constipation (CIC) Drugs Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Chronic Idiopathic Constipation (CIC) Drugs Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Chronic Idiopathic Constipation (CIC) Drugs Market Segments Table 2. Ranking of Global Top Chronic Idiopathic Constipation (CIC) Drugs Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million) Table 4. Major Manufacturers of Lubiprostone Table 5. Major Manufacturers of Linaclotide Table 6. Major Manufacturers of Others Table 7. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Growth Rate by Application 2020-2026 (K Units) Table 8. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026 Table 9. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Regions 2015-2020 (K Units) Table 10. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Regions (2015-2020) Table 11. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Regions 2015-2020 (US$ Million) Table 12. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Forecast by Region (2021-2026) (K Units) Table 13. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Manufacturers (2015-2020) (K Units) Table 14. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Manufacturers (2015-2020) Table 15. Global Chronic Idiopathic Constipation (CIC) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 16. Global Chronic Idiopathic Constipation (CIC) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Idiopathic Constipation (CIC) Drugs as of 2019) Table 17. Chronic Idiopathic Constipation (CIC) Drugs Revenue by Manufacturers (2015-2020) (US$ Million) Table 18. Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Manufacturers (2015-2020) Table 19. Key Manufacturers Chronic Idiopathic Constipation (CIC) Drugs Price (2015-2020) (USD/Unit) Table 20. Chronic Idiopathic Constipation (CIC) Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table 21. Manufacturers Chronic Idiopathic Constipation (CIC) Drugs Product Type Table 22. Date of International Manufacturers Enter into Chronic Idiopathic Constipation (CIC) Drugs Market Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans Table 24. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Type (2015-2020) (K Units) Table 25. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Type (2015-2020) Table 26. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2015-2020) (US$ Million) Table 27. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Type (2015-2020) Table 28. Chronic Idiopathic Constipation (CIC) Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit) Table 29. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Type (2021-2026) Table 30. Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Application (2015-2020) (K Units) Table 31. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Application (2015-2020) Table 32. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Application (2021-2026) Table 33. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share Forecast by Application (2021-2026) Table 34. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Application (2015-2020) (US$ Million) Table 35. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share Forecast by Application (2021-2026) Table 36. China Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units) of Key Companies (2015-2020) Table 37. China Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Company (2015-2020) Table 38. China Chronic Idiopathic Constipation (CIC) Drugs Revenue (US$ Million) by Company (2015-2020) Table 39. China Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units) by Type (2015-2020) Table 40. China Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Type (2015-2020) Table 41. China Chronic Idiopathic Constipation (CIC) Drugs Revenue (US$ Million) Market Share by Type (2015-2020) Table 42. China Chronic Idiopathic Constipation (CIC) Drugs Price (K Units) by Type (2015-2020) Table 43. China Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units) by Type (2021-2026) Table 44. China Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Type (2021-2026) Table 45. China Chronic Idiopathic Constipation (CIC) Drugs Revenue (US$ Million) Market Share by Type (2021-2026) Table 46. China Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Type (2021-2026) Table 47. China Chronic Idiopathic Constipation (CIC) Drugs Price (K Units) by Type (2021-2026) Table 48. China Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units) by Application (2015-2020) Table 49. China Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Application (2015-2020) Table 50. China Chronic Idiopathic Constipation (CIC) Drugs Revenue (US$ Million) Market Share by Application (2015-2020) Table 51. China Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units) by Application (2021-2026) Table 52. China Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Application (2021-2026) Table 53. China Chronic Idiopathic Constipation (CIC) Drugs Revenue (US$ Million) Market Share by Application (2021-2026) Table 54. China Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Application (2021-2026) Table 55. North America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2015-2020) (K Units) Table 56. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country (2015-2020) Table 57. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2015-2020) (US$ Million) Table 58. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Country (2015-2020) Table 59. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2015-2020) (K Units) Table 60. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country (2015-2020) Table 61. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2015-2020) (US$ Million) Table 62. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Country (2015-2020) Table 63. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales by Region (2015-2020) (K Units) Table 64. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Region (2015-2020) Table 65. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue by Region (2015-2020) (US$ Million) Table 66. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Region (2015-2020) Table 67. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2015-2020) (K Units) Table 68. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country (2015-2020) Table 69. Latin Americaa Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2015-2020) (US$ Million) Table 70. Latin America Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Country (2015-2020) Table 71. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales by Country (2015-2020) (K Units) Table 72. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country (2015-2020) Table 73. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue by Country (2015-2020) (US$ Million) Table 74. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Country (2015-2020) Table 75. Actavis Corporation Information Table 76. Actavis Description and Business Overview Table 77. Actavis Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 78. Actavis Chronic Idiopathic Constipation (CIC) Drugs Product Table 79. Actavis Recent Development Table 80. Chugai Pharmaceutical Corporation Information Table 81. Chugai Pharmaceutical Description and Business Overview Table 82. Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 83. Chugai Pharmaceutical Product Table 84. Chugai Pharmaceutical Recent Development Table 85. Ferring International Center Corporation Information Table 86. Ferring International Center Description and Business Overview Table 87. Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 88. Ferring International Center Product Table 89. Ferring International Center Recent Development Table 90. Synergy Pharmaceuticals Corporation Information Table 91. Synergy Pharmaceuticals Description and Business Overview Table 92. Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 93. Synergy Pharmaceuticals Product Table 94. Synergy Pharmaceuticals Recent Development Table 95. Pfizer Corporation Information Table 96. Pfizer Description and Business Overview Table 97. Pfizer Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 98. Pfizer Product Table 99. Pfizer Recent Development Table 100. GlaxoSmithKline Corporation Information Table 101. GlaxoSmithKline Description and Business Overview Table 102. GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 103. GlaxoSmithKline Product Table 104. GlaxoSmithKline Recent Development Table 105. Roche Holding Corporation Information Table 106. Roche Holding Description and Business Overview Table 107. Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 108. Roche Holding Product Table 109. Roche Holding Recent Development Table 110. Sanofi Corporation Information Table 111. Sanofi Description and Business Overview Table 112. Sanofi Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 113. Sanofi Product Table 114. Sanofi Recent Development Table 115. Bayer Corporation Information Table 116. Bayer Description and Business Overview Table 117. Bayer Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 118. Bayer Product Table 119. Bayer Recent Development Table 120. Salix Pharmaceuticals Corporation Information Table 121. Salix Pharmaceuticals Description and Business Overview Table 122. Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 123. Salix Pharmaceuticals Product Table 124. Salix Pharmaceuticals Recent Development Table 125. Sucampo Pharmaceuticals Corporation Information Table 126. Sucampo Pharmaceuticals Description and Business Overview Table 127. Sucampo Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 128. Sucampo Pharmaceuticals Product Table 129. Sucampo Pharmaceuticals Recent Development Table 130. Ironwood Pharmaceuticals Corporation Information Table 131. Ironwood Pharmaceuticals Description and Business Overview Table 132. Ironwood Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 133. Ironwood Pharmaceuticals Product Table 134. Ironwood Pharmaceuticals Recent Development Table 135. Progenics Pharmaceuticals Corporation Information Table 136. Progenics Pharmaceuticals Description and Business Overview Table 137. Progenics Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 138. Progenics Pharmaceuticals Product Table 139. Progenics Pharmaceuticals Recent Development Table 140. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 141. Key Challenges Table 142. Market Risks Table 143. Main Points Interviewed from Key Chronic Idiopathic Constipation (CIC) Drugs Players Table 144. Chronic Idiopathic Constipation (CIC) Drugs Customers List Table 145. Chronic Idiopathic Constipation (CIC) Drugs Distributors List Table 146. Research Programs/Design for This Report Table 147. Key Data Information from Secondary Sources Table 148. Key Data Information from Primary Sources List of Figures Figure 1. Chronic Idiopathic Constipation (CIC) Drugs Product Picture Figure 2. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type in 2020 & 2026 Figure 3. Lubiprostone Product Picture Figure 4. Linaclotide Product Picture Figure 5. Others Product Picture Figure 6. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application in 2020 & 2026 Figure 7. Hospitals & Clinics Figure 8. Ambulatory Surgical Centres Figure 9. Long Term Care Centres Figure 10. Others Figure 11. Chronic Idiopathic Constipation (CIC) Drugs Report Years Considered Figure 12. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size 2015-2026 (US$ Million) Figure 13. Global Chronic Idiopathic Constipation (CIC) Drugs Sales 2015-2026 (K Units) Figure 14. Global Chronic Idiopathic Constipation (CIC) Drugs Market Size Market Share by Region: 2020 Versus 2026 Figure 15. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Region (2015-2020) Figure 16. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Region in 2019 Figure 17. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Region (2015-2020) Figure 18. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Region in 2019 Figure 19. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Share by Manufacturer in 2019 Figure 20. The Top 10 and 5 Players Market Share by Chronic Idiopathic Constipation (CIC) Drugs Revenue in 2019 Figure 21. Chronic Idiopathic Constipation (CIC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 22. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type (2015-2020) Figure 23. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Type in 2019 Figure 24. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Type (2015-2020) Figure 25. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Type in 2019 Figure 26. Global Chronic Idiopathic Constipation (CIC) Drugs Market Share by Price Range (2015-2020) Figure 27. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application (2015-2020) Figure 28. Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Application in 2019 Figure 29. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Application (2015-2020) Figure 30. Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Application in 2019 Figure 31. China Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate 2015-2026 (K Units) Figure 32. China Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate 2015-2026 (US$ Million) Figure 33. China Chronic Idiopathic Constipation (CIC) Drugs Market Share in Global Market 2015-2026 Figure 34. China 5 and 10 Largest Chronic Idiopathic Constipation (CIC) Drugs Players Market Share by Revenue in Chronic Idiopathic Constipation (CIC) Drugs in 2019 Figure 35. China Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Type (2015-2020) Figure 36. China Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate by Type in 2015 & 2019 Figure 37. China Chronic Idiopathic Constipation (CIC) Drugs Revenue Share by Application (2015-2020) Figure 38. China Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate by Application in 2015 & 2019 Figure 39. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate 2015-2020 (K Units) Figure 40. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 41. North America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country in 2019 Figure 42. North America Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Country in 2019 Figure 43. U.S. Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 44. U.S. Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. Canada Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 46. Canada Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate 2015-2020 (K Units) Figure 48. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 49. Europe Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country in 2019 Figure 50. Europe Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Country in 2019 Figure 51. Germany Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 52. Germany Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. France Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 54. France Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. U.K. Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 56. U.K. Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Italy Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 58. Italy Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Russia Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 60. Russia Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate 2015-2020 (K Units) Figure 62. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 63. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Region in 2019 Figure 64. Asia Pacific Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Region in 2019 Figure 65. China Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 66. China Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Japan Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 68. Japan Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. South Korea Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 70. South Korea Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. India Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 72. India Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Australia Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 74. Australia Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Taiwan Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 76. Taiwan Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Indonesia Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 78. Indonesia Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Thailand Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 80. Thailand Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Malaysia Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 82. Malaysia Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 83. Philippines Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 84. Philippines Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 85. Vietnam Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 86. Vietnam Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 87. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate 2015-2020 (K Units) Figure 88. Latin America Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 89. Latin America Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country in 2019 Figure 90. Latin America Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Country in 2019 Figure 91. Mexico Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 92. Mexico Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 93. Brazil Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 94. Brazil Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 95. Argentina Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 96. Argentina Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 97. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate 2015-2020 (K Units) Figure 98. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 99. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Country in 2019 Figure 100. Middle East and Africa Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Country in 2019 Figure 101. Turkey Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 102. Turkey Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 103. Saudi Arabia Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 104. Saudi Arabia Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 105. U.A.E Chronic Idiopathic Constipation (CIC) Drugs Sales Growth Rate (2015-2020) (K Units) Figure 106. U.A.E Chronic Idiopathic Constipation (CIC) Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 107. Porter's Five Forces Analysis Figure 108. Chronic Idiopathic Constipation (CIC) Drugs Value Chain Figure 109. Channels of Distribution Figure 110. Distributors Profiles Figure 111. Bottom-up and Top-down Approaches for This Report Figure 112. Data Triangulation Figure 113. Key Executives Interviewed

Actavis Chugai Pharmaceutical Ferring International Center Synergy Pharmaceuticals Pfizer GlaxoSmithKline Roche Holding Sanofi Bayer Salix Pharmaceuticals Sucampo Pharmaceuticals Ironwood Pharmaceuticals Progenics Pharmaceuticals